Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The Future of Regenerative Peptide Therapy The field of peptide therapy continues to evolve as more research becomes available
Gastrointestinal and tendon/ligament research: BPC-157 has the most consistent preclinical signal here, including reported reductions in gastric ulcer surface area and accelerated tendon healing in rodent models
Bimagrumab is a human monoclonal antibody drug, whose mechanism of action stimulates the growth of skeletal muscle by blocking the activin type II receptor (ActRII)
Improper Storage Reconstituted BPC-157 requires consistent refrigeration
For example, N-acetylated versions of BPC-157 will likely be pushed through for patent soon
FAK-Paxillin Pathway and Cell Motility BPC-157 has been shown to activate the focal adhesion kinase (FAK)-paxillin signalling pathway, which governs cell motility, migration, and adhesion to the extracellular matrix
US$ 26.16
US$ 22.44
US$ 22.69
US$ 20.73
US$ 27.49
US$ 27.97
US$ 21.60
US$ 21.84
US$ 22.75
